Severe Jaw-Opening Dystonia as an Unusual Manifestation of Levodopa-Related in Parkinson's Disease, and Successful Treatment With Botulinum Toxin Injection.
作者信息
Agarwal Pankaj Ashok
机构信息
Movement Disorders Clinic, Department of Neurology Gleneagles Global Hospitals Mumbai Mumbai India.
Department of Neurology Seth GS Medical College and KEM Hospital Mumbai India.
出版信息
Mov Disord Clin Pract. 2019 May 29;6(6):500-501. doi: 10.1002/mdc3.12782. eCollection 2019 Jul.
Abstract
摘要
相似文献
1
Severe Jaw-Opening Dystonia as an Unusual Manifestation of Levodopa-Related in Parkinson's Disease, and Successful Treatment With Botulinum Toxin Injection.严重张口肌张力障碍作为帕金森病中左旋多巴相关的一种不寻常表现，以及肉毒杆菌毒素注射成功治疗。
Mov Disord Clin Pract. 2019 May 29;6(6):500-501. doi: 10.1002/mdc3.12782. eCollection 2019 Jul.
2
Successful treatment of open jaw and jaw deviation dystonia with botulinum toxin using a simple intraoral approach.采用简单的口内入路，肉毒杆菌毒素成功治疗开放性牙关紧闭和牙关偏斜肌张力障碍。
J Clin Neurosci. 2015 Mar;22(3):594-6. doi: 10.1016/j.jocn.2014.08.027. Epub 2014 Dec 23.
3
Oromandibular Dystonia: A Case Report of the Lateral Pterygoid Muscle Involvement and Treatment with Botulinum Toxin A.口下颌肌张力障碍：翼外肌受累及A型肉毒毒素治疗的病例报告
Clin Pract. 2016 Oct 10;6(3):862. doi: 10.4081/cp.2016.862. eCollection 2016 Aug 8.
4
The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.化学去神经支配在 X 连锁型肌张力障碍-帕金森病中的广泛应用（第二部分）：使用肉毒毒素 A（Dysport®）注射治疗口颌部、舌部和躯干-脊柱部肌张力障碍的开放性经验。
Int J Neurosci. 2011;121 Suppl 1:44-56. doi: 10.3109/00207454.2011.558260.
5
An update on the use of botulinum toxin therapy in Parkinson's disease.关于肉毒毒素治疗帕金森病的最新进展。
Curr Neurol Neurosci Rep. 2015 Jan;15(1):511. doi: 10.1007/s11910-014-0511-3.
6
Oromandibular dystonia: long-term management with botulinum toxin.口颌肌张力障碍：肉毒毒素的长期治疗。
Laryngoscope. 2013 Dec;123(12):3078-83. doi: 10.1002/lary.23265. Epub 2013 Oct 5.
7
Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.肉毒杆菌毒素A治疗继发于威尔逊病的张口型口下颌肌张力障碍
Arq Neuropsiquiatr. 2012 Jun;70(6):407-9. doi: 10.1590/s0004-282x2012000600005.
8
How Do I Inject Botulinum Toxin Into the Lateral and Medial Pterygoid Muscles?如何将肉毒杆菌毒素注射到翼外肌和翼内肌？
Mov Disord Clin Pract. 2016 Dec 14;4(2):285. doi: 10.1002/mdc3.12460. eCollection 2017 Mar-Apr.
9
Computer-Aided Design/Computer-Assisted Manufacture-Derived Needle Guide for Injection of Botulinum Toxin into the Lateral Pterygoid Muscle in Patients with Oromandibular Dystonia.计算机辅助设计/计算机辅助制造引导针用于治疗口颌肌张力障碍患者的翼外肌注射肉毒毒素。
J Oral Facial Pain Headache. 2018;32(2):e13-e21. doi: 10.11607/ofph.1955.
10
[Parkinsonian dystonia].帕金森病性肌张力障碍
Rev Neurol (Paris). 2003 Oct;159(10 Pt 1):928-31.
引用本文的文献
1
Jaw-opening dystonia in Parkinson's disease improved by foslevodopa-foscarbidopa continuous subcutaneous infusion: a case report.福司来沃多巴-福司卡比多巴持续皮下输注改善帕金森病性张口肌张力障碍：一例报告
Neurol Sci. 2024 Dec;45(12):5939-5941. doi: 10.1007/s10072-024-07740-0. Epub 2024 Sep 3.
2
Use of botulinum toxin in the management of dystonia in Parkinson's disease.肉毒杆菌毒素在帕金森病肌张力障碍治疗中的应用。
Front Neurosci. 2024 Apr 8;18:1371601. doi: 10.3389/fnins.2024.1371601. eCollection 2024.
3
Severe jaw-opening off-dystonia in Parkinson's disease masked by effective deep brain stimulation of the subthalamic nucleus.帕金森病中严重的下颌张开性肌张力障碍被丘脑底核有效的深部脑刺激所掩盖。
Neurol Sci. 2022 Feb;43(2):1449-1450. doi: 10.1007/s10072-021-05780-4. Epub 2021 Nov 26.
本文引用的文献
1
Prominent Oromandibular Dystonia as Levodopa-induced Dyskinesia in Idiopathic Parkinson's Disease.显著的口下颌肌张力障碍作为特发性帕金森病中左旋多巴诱发的异动症
Mov Disord Clin Pract. 2019 Apr 15;6(4):330-331. doi: 10.1002/mdc3.12759. eCollection 2019 Apr.
2
Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients.口下颌肌张力障碍：240例患者的人口统计学和临床数据
J Mov Disord. 2018 May;11(2):78-81. doi: 10.14802/jmd.17065. Epub 2018 May 30.
3
Levodopa-induced lateral jaw deviation dystonia.
Parkinsonism Relat Disord. 2015 Jul;21(7):808. doi: 10.1016/j.parkreldis.2015.02.012. Epub 2015 Apr 25.
4
Dystonia in Parkinson's disease.帕金森病中的肌张力障碍
J Neurol. 2006 Dec;253 Suppl 7:VII7-13. doi: 10.1007/s00415-006-7003-6.
5
End-of-dose dystonia in Parkinson's disease.
Neurology. 1993 Oct;43(10):2130-1. doi: 10.1212/wnl.43.10.2130.
6
Forms of dystonia in patients with Parkinson's disease.帕金森病患者的肌张力障碍形式。
Neurology. 1987 Jun;37(6):1009-11. doi: 10.1212/wnl.37.6.1009.
7
Dystonia in Parkinson's disease: clinical and pharmacological features.帕金森病中的肌张力障碍：临床和药理学特征
Ann Neurol. 1988 Jan;23(1):73-8. doi: 10.1002/ana.410230112.
8
"Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease.左旋多巴治疗的帕金森病患者的“关期”肌张力障碍和“开期”舞蹈手足徐动症。
Lancet. 1977 Nov 12;2(8046):1034. doi: 10.1016/s0140-6736(77)92939-7.
Zotero 插件